The two US based pharmaceutical companies Bristol-Myers Squibb and Pfizer are thrilled with the news that their experimental anti-coagulant drug Eliquis has passed a late stage trial (third phase) successfully. Both the firms have ecstatically announced success at the third phase of the trial (ARISTOTLE) of the drug. The trial was conducted for patients suffering Read more